DiscussierStructure Therapeutics
Clinical-stage biotech developing oral small molecule drugs targeting G protein-coupled receptors, including oral GLP-1 agonists for obesity treatment.
Clinical-stage biotech developing oral small molecule drugs targeting G protein-coupled receptors, including oral GLP-1 agonists for obesity treatment.